Literature DB >> 9726836

Induction of cyclooxygenase (COX)-2 but not COX-1 gene expression in apoptotic cell death.

L Ho1, H Osaka, P S Aisen, G M Pasinetti.   

Abstract

In this study we assessed the regulation of cyclooxygenase (COX)-2 in models of apoptotic cell death in vivo and in vitro. By 6 h after hippocampal colchicine injection in rat, COX-2 (but not COX-1) mRNA expression was elevated. The induction of COX-2 mRNA expression preceded temporally and overlapped anatomically the cellular morphological features of apoptosis in the granule cell layer of the dentate gyrus. Similarly, in an established in vitro model of apoptosis in P19 cells, COX-2 induction preceded apoptosis in response to serum deprivation by 12 h. These studies suggest that COX-2 may be involved in the early mechanisms leading to apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9726836     DOI: 10.1016/s0165-5728(98)00132-5

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

Review 1.  Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease.

Authors:  P L McGeer
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

2.  The cyclooxygenase site, but not the peroxidase site of cyclooxygenase-2 is required for neurotoxicity in hypoxic and ischemic injury.

Authors:  Wenjin Li; Shasha Wu; Muzamil Ahmad; Jianfei Jiang; Hao Liu; Tetsuya Nagayama; Marie E Rose; Vladimir A Tyurin; Yulia Y Tyurina; Grigory G Borisenko; Natalia Belikova; Jun Chen; Valerian E Kagan; Steven H Graham
Journal:  J Neurochem       Date:  2010-03-17       Impact factor: 5.372

Review 3.  Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease?

Authors:  Lap Ho; Weiping Qin; Breton S Stetka; Giulio M Pasinetti
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 4.  Inflammation and Alzheimer's disease.

Authors:  H Akiyama; S Barger; S Barnum; B Bradt; J Bauer; G M Cole; N R Cooper; P Eikelenboom; M Emmerling; B L Fiebich; C E Finch; S Frautschy; W S Griffin; H Hampel; M Hull; G Landreth; L Lue; R Mrak; I R Mackenzie; P L McGeer; M K O'Banion; J Pachter; G Pasinetti; C Plata-Salaman; J Rogers; R Rydel; Y Shen; W Streit; R Strohmeyer; I Tooyoma; F L Van Muiswinkel; R Veerhuis; D Walker; S Webster; B Wegrzyniak; G Wenk; T Wyss-Coray
Journal:  Neurobiol Aging       Date:  2000 May-Jun       Impact factor: 4.673

5.  Prolonged cyclooxygenase-2 induction in neurons and glia following traumatic brain injury in the rat.

Authors:  K I Strauss; M F Barbe; R M Marshall; R Raghupathi; S Mehta; R K Narayan
Journal:  J Neurotrauma       Date:  2000-08       Impact factor: 5.269

6.  Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2.

Authors:  K A Kelley; L Ho; D Winger; J Freire-Moar; C B Borelli; P S Aisen; G M Pasinetti
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

7.  Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.

Authors:  Peter Klivenyi; Gabrielle Gardian; Noel Y Calingasan; Lichuan Yang; M Flint Beal
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 8.  Rodent models of neuroinflammation for Alzheimer's disease.

Authors:  Amir Nazem; Roman Sankowski; Michael Bacher; Yousef Al-Abed
Journal:  J Neuroinflammation       Date:  2015-04-17       Impact factor: 8.322

Review 9.  Role of anti-diabetic drugs as therapeutic agents in Alzheimer's disease.

Authors:  Syed Mohd Danish Rizvi; Sibhghatulla Shaikh; Shah Mohammad Abbas Waseem; Shazi Shakil; Adel M Abuzenadah; Deboshree Biswas; Shams Tabrez; Ghulam Md Ashraf; Mohammad Amjad Kamal
Journal:  EXCLI J       Date:  2015-05-19       Impact factor: 4.068

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.